Role of Epstein‐Barr virus and soluble CD21 in persistent polyclonal B‐cell lymphocytosis (Q41329469)

29 September 2017

title

Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis (English)

1 reference

29 September 2017

Role of Epstein‐Barr virus and soluble CD21 in persistent polyclonal B‐cell lymphocytosis (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

13 July 2024

0 references

C. Larcher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7646990

13 July 2024

F. Fend

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7646990

13 July 2024

M. Mitterer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7646990

13 July 2024

N. Prang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7646990

13 July 2024

F. Schwarzmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7646990

13 July 2024

H. P. Huemer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7646990

13 July 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

full work available at URL

29 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.1995.tb05580.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.1995.tb05580.x

13 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

British Journal of Haematology

13 July 2024

published in

1 reference

29 September 2017

volume

90

1 reference

29 September 2017

issue

3

1 reference

29 September 2017

page(s)

532-540

1 reference

CD21 is a ligand for CD23 and regulates IgE production

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc epsilon RII monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Chronic fatigue syndrome: a working case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Identification of type A and B isolates of Epstein-Barr virus by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Epstein-Barr virus regulates activation and processing of the third component of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Regulation of lymphocyte blastogenesis and antibody production by soluble factor released by a human B-lymphoblastoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Identification and characterization of a novel membrane activation antigen with wide cellular distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

A Transformation-Incompetent, Nuclear Antigen 2-Deleted Epstein-Barr Virus Associated with Replicative Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Cloning and mapping of BamHi endonuclease fragments of DNA from the transforming B95-8 strain of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

Tumor initiators and promoters in the induction of Epstein—Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05580.X

The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Persistent polyclonal lymphocytosis of B lymphocytes, induced by cigarette smoking?

13 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridization

13 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

13 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Persistent polyclonal lymphocytosis of B lymphocytes

13 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes

13 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Determination of soluble CD21 as a parameter of B cell activation

13 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Sites of Epstein-Barr virus replication in acute and chronic active Epstein-Barr virus infections

13 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia

13 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination

13 July 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Chronic active Epstein‐Barr virus disease in a case of persistent polyclonal B‐cell lymphocytosis

13 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.

13 July 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

13 July 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE

13 July 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1995.TB05580.X

13 July 2024

Identifiers

1 reference

29 September 2017

1 reference